We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Authors
Laure Dossus; James D. McKay; Federico Canzian; Stefan Wilkening; Sabina Rinaldi; Carine Biessy; Anja Olsen; Anne Tjønneland; Marianne U. Jakobsen; Kim Overvad; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Agnes Fournier; Jakob Linseisen; Annekatrin Lukanova; Heiner Boeing; Eva Fisher; Antonia Trichopoulou; Christina Georgila; Dimitrios Trichopoulos
- Abstract
Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, has two major functions: the stimulation of the growth hormone production and the stimulation of food intake. Accumulating evidence also suggests a role of ghrelin in cancer development. We conducted a case–control study on 1359 breast cancer cases and 2389 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition, to examine the association of common genetic variants in the genes coding for ghrelin (GHRL) and its receptor (GHSR) with anthropometric measures, circulating insulin growth factor I (IGF-I) and insulin-like growth factor-binding protein 3 and breast cancer risk. Pair-wise tagging was used to select the 15 polymorphisms that represent the majority of common genetic variants across the GHRL and GHSR genes. A significant increase in breast cancer risk was observed in carriers of the GHRL rs171407-G allele (odds ratio: 1.2; 95% confidence interval: 1.0–1.4; P = 0.02). The GHRL single-nucleotide polymorphism rs375577 was associated with a 5% increase in IGF-I levels (P = 0.01). A number of GHRL and GHSR polymorphisms were associated with body mass index (BMI) and height (P between GHRL variations are associated with BMI. Furthermore, we have observed evidence for association of GHRL polymorphisms with circulating IGF-I levels and with breast cancer risk. These associations, however, might also be due to chance findings and further large studies are needed to confirm our results.
- Subjects
BREAST cancer research; GENETIC polymorphisms; BREAST cancer; GHRELIN; ANTHROPOMETRY; CANCER risk factors; NUTRITION disorders
- Publication
Carcinogenesis, 2008, Vol 29, Issue 7, p1360
- ISSN
0143-3334
- Publication type
Article
- DOI
10.1093/carcin/bgn083